India's Sun Pharma in Talks to Buy Sweden's Meda for $5-$6 Billion

01.06.2013 - India's Sun Pharmaceutical Industries is in talks to buy Sweden's Meda for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with...